News

SEARCH FIRM NEWS

news October 21, 2025

“How to Navigate GLP-1 Supplement Claims and Compliance” by Rend Al-Mondhiry

Interest in GLP-1 products has grown exponentially over the past year. With this growth has come questions and scrutiny around the types of claims that can be made for dietary supplements intended for GLP-1 support — and rightly so, as there are boundaries regarding what can be said about the benefits of these products, and […]

news September 5, 2025

Rend Al-Mondhiry Quoted in “Supplements for Bruising? Products Walk a Regulatory Fine Line Amid Surging Consumer Demand”

NutraIngredients USA turned to Rend Al-Mondhiry for commentary on the increasing demand for nutritional support by surgical patients looking to speed up their recovery. Read the full story here.

news August 21, 2025

Best Lawyers in America 2026 Spotlights Amin Wasserman Gurnani Attorneys

The Best Lawyers in America has recognized Amin Wasserman Gurnani attorneys in its 2026 edition, lauding their work in multiple practice areas.

news August 5, 2025

Jennifer Adams Quoted in “Dr. Squatch Ends Select TikTok Shop Affiliate Posts Amid Disclosure Scrutiny”

Cosmetics Design turned to Jennifer Adams for comment on an NAD decision highlighting the growing scrutiny of influencer marketing practices and the limitations of platform-based disclosure tools. Click here to read the full story.

news August 4, 2025

Ivan Wasserman Quoted in “FTC Warns Companies About ‘Made in USA’ Compliance Requirements”

NutraIngredients USA turned to Ivan Wasserman for comment on warning letters sent by the FTC to companies claiming their products are ‘Made in the USA’. The letters explained how the agency’s requirements apply to online marketplaces.

news July 30, 2025

WHOOP! FDA Raises Compliance Pressures for Wearable Manufacturers

On July 14, 2025, FDA issued a Warning Letter to WHOOP, Inc. concerning its Blood Pressure Insights (BPI) feature, which the company had positioned as a non-regulated general wellness product. FDA asserted it was an unapproved medical device that required 510(k) clearance. This action could represent a significant shift in FDA’s enforcement priorities, which could […]

news July 14, 2025

Amin Wasserman Gurnani Expands its Leading Prop 65 Practice with Partner Additions Rebecca Lee and Jennifer Singh

 Los Angeles, CA, July 14, 2025–Amin Wasserman Gurnani (AWG) is pleased to announce the addition of partners Rebecca Lee and Jennifer Singh to the firm’s Litigation and Prop 65 practice groups, expanding its team of highly experienced attorneys offering dispute resolution, trial practice, and Prop 65 counseling and litigation services.

news May 6, 2025

Jennifer Adams Quoted in “NARB Upholds NAD Ruling Against Olly’s Kids Chillax Advertising Claims”

NutraIngredients-USA turned to FTC & State Advertising Compliance Practice Group Co-Chair Jennifer Adams for comment on the latest in a series of cases spotlighting the intersection of clinical substantiation, demographic targeting, and compliance with advertising standards in the dietary supplements sector. Jennifer stated, “This case highlights that study design matters more than the results. NARB’s […]

What's Now

Ivan Wasserman Quoted in “FDA Shakeup: Makary Steps Down, Diamantas Steps Up”

In its coverage of the leadership shakeup at FDA and the appointment of a new commissioner, NutraIngredients turned to Ivan Wasserman for comment.

see all news >